Elite Pharmaceuticals, Inc. Common Stock (OTCMKTS:ELTP) issued its earnings results on Thursday. The specialty pharmaceutical company reported $0.00 EPS for the quarter, Zacks Earnings Dates reports. Elite Pharmaceuticals, Inc. Common Stock had a negative net margin of 55.87% and a negative return on equity of 38.74%.
Elite Pharmaceuticals, Inc. Common Stock traded up $0.00, reaching $0.09, during trading on Thursday, MarketBeat.com reports. 431,739 shares of the stock were exchanged, compared to its average volume of 731,408. The company has a quick ratio of 2.00, a current ratio of 3.11 and a debt-to-equity ratio of 0.56. Elite Pharmaceuticals, Inc. Common Stock has a 1 year low of $0.06 and a 1 year high of $0.21.
About Elite Pharmaceuticals, Inc. Common Stock
Elite Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the research, development, manufacture, and licensing of proprietary orally administered controlled-release drug delivery systems and products. The company operates in two segments, Abbreviated New Drug Applications for Generic Products and New Drug Applications for Branded Products.
Receive News & Ratings for Elite Pharmaceuticals Inc. Common Stock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elite Pharmaceuticals Inc. Common Stock and related companies with MarketBeat.com's FREE daily email newsletter.